No paralogue variants have been mapped to residue 155 for CACNA1C.
CACNA1C | PFEIIILLTIFANCVALAIYIPFPEDDSNA>T<NSNLERVEYLFLI-IFTVEAFLKVIAYGLL | 184 |
CACNA1A | PFEYMILATIIANCIVLALEQHLPDDDKTP>M<SERLDDTEPYFIG-IFCFEAGIKIIALGFA | 158 |
CACNA1B | PFEYMILATIIANCIVLALEQHLPDGDKTP>M<SERLDDTEPYFIG-IFCFEAGIKIIALGFV | 155 |
CACNA1D | PFDIFILLAIFANCVALAIYIPFPEDDSNS>T<NHNLEKVEYAFLI-IFTVETFLKIIAYGLL | 186 |
CACNA1E | PFEYMILATIIANCIVLALEQHLPEDDKTP>M<SRRLEKTEPYFIG-IFCFEAGIKIVALGFI | 149 |
CACNA1F | PFDILILLTIFANCVALGVYIPFPEDDSNT>A<NHNLEQVEYVFLV-IFTVETVLKIVAYGLV | 152 |
CACNA1G | WFERISMLVILLNCVTLGMFRPCEDIACDS>Q<RCRILQAFDDFIFAFFAVEMVVKMVALGI- | 141 |
CACNA1H | WFEHVSMLVIMLNCVTLGMFRPCEDVECGS>E<RCNILEAFDAFIFAFFAVEMVIKMVALGL- | 160 |
CACNA1I | WFECVSMLVILLNCVTLGMYQPCDDMDCLS>D<RCKILQVFDDFIFIFFAMEMVLKMVALGI- | 139 |
CACNA1S | PFETIILLTIFANCVALAVYLPMPEDDNNS>L<NLGLEKLEYFFLI-VFSIEAAMKIIAYGFL | 111 |
SCN10A | WFSLFITVTILVNCVCMTRT------D-LP>E<-----KIEYVFTV-IYTFEALIKILARGFC | 178 |
SCN11A | LFSMFIIGTVIINCVFMATGPA-K--NSNS>N<NT--DIAECVFTG-IYIFEALIKILARGFI | 184 |
SCN1A | LFSMLIMCTILTNCVFMTMS------N-PP>D<WT--KNVEYTFTG-IYTFESLIKIIARGFC | 179 |
SCN2A | LFNMLIMCTILTNCVFMTMS------N-PP>D<WT--KNVEYTFTG-IYTFESLIKILARGFC | 180 |
SCN3A | LFSMLIMCTILTNCVFMTLS------N-PP>D<WT--KNVEYTFTG-IYTFESLIKILARGFC | 179 |
SCN4A | LFSMFIMITILTNCVFMTMS------D-PP>P<WS--KNVEYTFTG-IYTFESLIKILARGFC | 182 |
SCN5A | LFNMLIMCTILTNCVFMAQH------D-PP>P<WT--KYVEYTFTA-IYTFESLVKILARGFC | 182 |
SCN7A | FFQLFILISVLIDCVFMSLT------N-LP>K<WR--PVLENTLLG-IYTFEILVKLFARGVW | 169 |
SCN8A | VFSMIIMCTILTNCVFMTFS------N-PP>D<WS--KNVEYTFTG-IYTFESLVKIIARGFC | 183 |
SCN9A | LFSMLIMCTILTNCIFMTMN------N-PP>D<WT--KNVEYTFTG-IYTFESLVKILARGFC | 177 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.T155A | c.463A>G | Putative Benign | SIFT: Polyphen: |